BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9451669)

  • 1. Intragastric distribution of nonsteroidal anti-inflammatory drug-related ulcers in patients without collagen diseases.
    Waki S; Kinoshita Y; Fukui H; Maekawa T; Okada A; Matsushima Y; Hassan S; Sakatani T; Kawanami C; Kishi K; Chiba T
    J Clin Gastroenterol; 1997 Dec; 25(4):592-4. PubMed ID: 9451669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
    Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
    Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
    Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
    J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis.
    Tanaka E; Kamitsuji S; Inoue E; Yamada T; Nakajima A; Takeuchi E; Yanagisawa A; Misaka R; Shigemoto M; Yamashita K; Imamura T; Hara M; Tomatsu T; Saito T; Lauren G; Triadafilopoulos G; Kamatani N; Singh G; Yamanaka H
    Mod Rheumatol; 2007; 17(3):228-34. PubMed ID: 17564779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.
    Lancaster-Smith MJ; Jaderberg ME; Jackson DA
    Gut; 1991 Mar; 32(3):252-5. PubMed ID: 2013419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
    Laine L; Marin-Sorensen M; Weinstein WM
    Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-nonsteroidal anti-inflammatory drug, nonmalignant gastric ulcers.
    Bjorkman DJ; Ziebert J
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):527-44. PubMed ID: 8803566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM; McHenry L; Sanyal AJ
    Gastroenterologist; 1993 Jun; 1(2):165-9. PubMed ID: 8049889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial.
    Elliott SL; Yeomans ND; Buchanan RR; Smallwood RA
    Scand J Rheumatol; 1994; 23(4):171-6. PubMed ID: 8091141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
    Kobata Y; Yajima H; Yamao J; Tanaka Y; Fukui H; Takakura Y
    Mod Rheumatol; 2009; 19(6):629-36. PubMed ID: 19728013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.